Telik

Telik, Inc. was set up in 1988 and was reverse merged into privately held MabVax in May 2014.[1] The major drug of the company was TELINTRA, an investigational agent that was in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.[2]

Telik Inc
IndustryHealthcare, Drug Manufacturers - Other
Founded1988
Headquarters
Palo Alto, California
,
United States
Key people
Michael M. Wick M.D.
( Chairman, Chief Executive Officer, and President)

Wendy K. Wee
( Principal Financial & Accounting Officer )

Gail L. Brown M.D.
( Chief Medical Officer )
(Dec 31, 2012)
Number of employees
17 (Dec 31, 2012)
Websitetelik.com Edit this on Wikidata

Controversies

In 2007, a class action was filed against Telik, Inc., alleging that they made false and misleading statements about the Company’s business and prospects during the Class Period.[3]

References
  1. "Reverse merger".
  2. "Business Summary".
  3. "Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Telik, Inc".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.